Diasorin

Multinational biotech company.

Launch date

1968

Employees

1001-5000 people

Market cap

Enterprise valuation

CAD9.4b (Public information from Sep 2024)

Saluggia Piedmont (HQ & founding location)

http://www.diasorin.com

https://twitter.com/diasoringroup https://www.linkedin.com/company/diasorin https://apps.apple.com/app/id931936203 https://play.google.com/store/apps/details?id=it.e_gate.diasorin

Revenues, earnings & profits over time

EUR	2020	2021	2022	2023	2024	2025	2026
Revenues	881m	1.2b	1.4b	1.1b	1.2b	1.3b	1.4b
% growth	25 %	40 %	10 %	(16 %)	4 %	8 %	8 %
EBITDA	392m	539m	534m	388m	390m	430m	483m
% EBITDA margin	44 %	44 %	39 %	34 %	33 %	33 %	35 %
Profit	248m	311m	241m	165m	190m	218m	251m
% profit margin	28 %	25 %	18 %	14 %	16 %	17 %	18 %
EV / revenue	10.2x	8.2x	5.8x	5.0x	5.2x	4.7x	4.2x
EV / EBITDA	22.9x	18.8x	14.7x	14.8x	15.9x	14.1x	12.2x
R&D budget	50.8m	70.1m	96.9m	-	-	-	-
R&D % of revenue	6 %	6 %	7 %	-	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
Jul 2007	N/A	N/A	IPO
Mar 2020	ASPR	$697k	Grant
Apr 2020	ASPR	$180k	Grant
Jul 2020	ASPR	$111k	Grant
Nov 2020	ASPR	$820k	Grant
Total Funding		CAD2.5m

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Diasorin Apr 2021